Tamoxifen Citrate(nolvadex)
Inquiry
| Post Date: | Dec 19,2015 |
| Expiry Date: | Jun 16,2016 |
| Detailed Description: |
Cas No. :54965-24-1
Payment Method: T/T,money gram,western union Tamoxifen Citrate (Nolvadex) Product Name: Tamoxifen Citrate (Nolvadex) Synonyms: 1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;NOLVADEX;TAMOXIFEN CITRATE;TAMOXIFEN CITRATE SALT;Z-1-(P-DIMETHYLAMINOETHOXYPHENYL)-1,2-DIPHENYL-1-BUTENE CITRATE;(Z)-2-[4-(1,2-DIPHENYL-1-BUTENYL)PHENOXY]-N,N-DIMETHYLETHANAMINE CITRATE;(z)-2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethanamine,citrate(1:;(z)-2-(para-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethylaminecitrate(;2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethyl-ethanamin(z)-ethanamin2-hydrox;ici46,474;kessar;noltam;tamofen;tamoxasta;terimon;trans-1-(p-beta-dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-enecitrate;y-1,2,3-propanetricarboxylate(1:1);z-tamoxifencitrate;; CAS No.: 54965-24-1 EINECS No.: 259-415-2 Molecular Formula: C32H37NO8 Molecular Weight: 563.64 Melting point: 140-144 °C Appearance: white crystalline powder Standard: Enterprise Standard Packing: 25KG/Drum or as per your requirements Application: Applied to the treatment of advanced, recurrent breast cancer and ovarian cancer. Storage Condition: 2-8°C Catagory: Active Pharmaceutical Ingredients;Antitumors for Research and Experimental Use;Biochemistry;API's;Intracellular receptor;pharmaceutical raw material;Steroid and Hormone;API;SOLTAMOX;antineoplastic drug |
| CAS Registry Number: | 54965-24-1 |
| Synonyms: | ;(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;Tamoxiphen Citrate;2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt); |
| Molecular Formula: | C32H34NO8 |
| Molecular Weight: | 560.6159 |
| Molecular Structure: | 
|
| Hazard Symbols: |  T:Toxic; |
| Risk Codes: | R22:; R45:; |
| Safety Description: | S45:; S53:; |
| Company: | Hubei Yuancheng Pharmaceutical Co.,Ltd [ China ] |
| Contact: | Sadiya |
| Tel: | +86-027-50756084 |
| Fax: | |
| Email: | sales09@ycphar.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
